OFS Plus Exemestane Improves DFS in Early Breast Cancer|ASCO Annual Meeting
http://am.asco.org/ofs-plus-exemestane-improves-dfs-early-breast-cancer?j=33859285&e=drchiragashah%40gmail.com&l=18383336_HTML&u=424895036&mid=10297795&jb=0&et_cid=33859285&et_rid=463478847&linkid=Abstract%20LBA%201%20–%20Aromatase%20Inhibitor%20Better%20Adjuvant%20Breast%20Cancer%20Therapy%20than%20Tamoxifen%20for%20Premenopausal%20Women%20with%20Suppressed%20Ovarian%20Function
More